Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 2,780,000 shares, a growth of 7.8% from the September 15th total of 2,580,000 shares. Currently, 7.6% of the company's shares are short sold. Based on an average daily trading volume, of 905,500 shares, the days-to-cover ratio is currently 3.1 days.
Amprius Technologies Price Performance
NYSE:AMPX traded up $0.06 on Wednesday, hitting $1.33. 1,604,453 shares of the company's stock were exchanged, compared to its average volume of 806,067. The firm has a 50-day moving average price of $1.04 and a 200-day moving average price of $1.34. Amprius Technologies has a 52 week low of $0.61 and a 52 week high of $6.02. The company has a market cap of $143.60 million, a P/E ratio of -2.95 and a beta of 2.71.
Amprius Technologies (NYSE:AMPX - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.02). The company had revenue of $3.35 million for the quarter, compared to the consensus estimate of $2.45 million. Amprius Technologies had a negative return on equity of 64.85% and a negative net margin of 327.05%. During the same quarter in the previous year, the company posted ($0.11) EPS. On average, research analysts expect that Amprius Technologies will post -0.5 earnings per share for the current fiscal year.
Insider Buying and Selling at Amprius Technologies
In related news, CEO Kang Sun sold 33,333 shares of Amprius Technologies stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $1.04, for a total transaction of $34,666.32. Following the transaction, the chief executive officer now owns 1,350,753 shares of the company's stock, valued at $1,404,783.12. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Kang Sun sold 33,333 shares of the firm's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $1.04, for a total transaction of $34,666.32. Following the sale, the chief executive officer now owns 1,350,753 shares of the company's stock, valued at approximately $1,404,783.12. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Justin E. Mirro sold 250,000 shares of Amprius Technologies stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $0.81, for a total value of $202,500.00. Following the transaction, the director now owns 1,195,000 shares in the company, valued at approximately $967,950. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 469,683 shares of company stock valued at $425,318. 12.80% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Amprius Technologies
Several large investors have recently made changes to their positions in AMPX. AQR Capital Management LLC bought a new position in Amprius Technologies during the second quarter worth about $99,000. XTX Topco Ltd acquired a new stake in shares of Amprius Technologies in the second quarter valued at approximately $72,000. Finally, B. Riley Wealth Advisors Inc. boosted its stake in shares of Amprius Technologies by 84.4% during the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 22,500 shares of the company's stock worth $29,000 after acquiring an additional 10,300 shares during the period. Institutional investors and hedge funds own 5.04% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on AMPX. Oppenheimer lowered their target price on Amprius Technologies from $15.00 to $14.00 and set an "outperform" rating for the company in a research note on Friday, August 9th. Roth Mkm dropped their price objective on shares of Amprius Technologies from $10.00 to $6.00 and set a "buy" rating on the stock in a report on Friday, August 9th. Northland Capmk raised shares of Amprius Technologies to a "strong-buy" rating in a research report on Wednesday, October 2nd. HC Wainwright reiterated a "buy" rating and set a $10.00 target price on shares of Amprius Technologies in a report on Monday, August 12th. Finally, Northland Securities dropped their price target on Amprius Technologies from $10.00 to $4.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 13th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, Amprius Technologies presently has a consensus rating of "Buy" and a consensus price target of $8.17.
View Our Latest Report on Amprius Technologies
About Amprius Technologies
(
Get Free Report)
Amprius Technologies, Inc produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
Recommended Stories
Before you consider Amprius Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.
While Amprius Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.